ImpediMed Limited
ASX:IPD.AX
0.055 (AUD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 10.319 | 11.344 | 10.566 | 8.409 | 5.741 | 4.156 | 3.318 | 5.766 | 5.791 | 4.844 | 3.521 | 2.733 | 2.945 | 3.887 | 3.639 | 2.992 | 2.311 | 0 |
Cost of Revenue
| 24.295 | 24.998 | 23.916 | 20.611 | 18.629 | 1.252 | 0.976 | 1.489 | 1.583 | 1.324 | 0.968 | 1.174 | 1.265 | 1.656 | 1.609 | 1.427 | 0.694 | 0 |
Gross Profit
| -13.976 | -13.654 | -13.35 | -12.202 | -12.888 | 2.904 | 2.342 | 4.277 | 4.208 | 3.52 | 2.553 | 1.559 | 1.68 | 2.231 | 2.03 | 1.565 | 1.618 | 0 |
Gross Profit Ratio
| -1.354 | -1.204 | -1.263 | -1.451 | -2.245 | 0.699 | 0.706 | 0.742 | 0.727 | 0.727 | 0.725 | 0.57 | 0.57 | 0.574 | 0.558 | 0.523 | 0.7 | 0 |
Reseach & Development Expenses
| 0.221 | 0.598 | 0.683 | 1.456 | 3.308 | 3.365 | 2.964 | 5.336 | 4.041 | 1.035 | 0.401 | 0.554 | 2.783 | 1.379 | 1.265 | 2.928 | 1.828 | 0 |
General & Administrative Expenses
| 22.095 | 5.325 | 4.85 | 4.865 | 4.608 | 4.495 | 6.993 | 6.107 | 7.728 | 3.525 | 3.036 | 3.119 | 7.617 | 11.369 | 8.006 | 6.475 | 4.673 | 0 |
Selling & Marketing Expenses
| 0.524 | 0.458 | 0.669 | 0.447 | 0.875 | 0.714 | 0.819 | 1.195 | 1.295 | 1.296 | 0.477 | 0.454 | 0.777 | 0.499 | 0.165 | 0.646 | 0.403 | 0 |
SG&A
| 9.777 | 8.594 | 7.194 | 9.359 | 9.314 | 22.834 | 29.673 | 29.466 | 28.482 | 17.482 | 10.051 | 10.257 | 8.394 | 11.868 | 8.171 | 7.121 | 5.076 | 0 |
Other Expenses
| 3.081 | 1.703 | 1.691 | 2.437 | 4.189 | 2.696 | 3.063 | -0.56 | 0.043 | 0.265 | 0.01 | 0.791 | 0.777 | 0.084 | 0.052 | 0.063 | 1.121 | 0 |
Operating Expenses
| 9.998 | 9.192 | 7.877 | 10.815 | 12.622 | 27.22 | 29.976 | 32.175 | 30.344 | 18.4 | 10.545 | 10.215 | 15.145 | 17.485 | 13.722 | 15.73 | 11.457 | 0 |
Operating Income
| -23.974 | -22.846 | -21.227 | -23.017 | -25.51 | -26.96 | -30.712 | -30.78 | -28.499 | -15.145 | -8.011 | -9.447 | -13.465 | -15.254 | -11.692 | -14.165 | -9.809 | 0 |
Operating Income Ratio
| -2.323 | -2.014 | -2.009 | -2.737 | -4.443 | -6.487 | -9.256 | -5.338 | -4.921 | -3.127 | -2.275 | -3.457 | -4.572 | -3.924 | -3.213 | -4.734 | -4.244 | 0 |
Total Other Income Expenses Net
| 3.249 | 0.77 | -0.22 | 0.562 | 1.575 | 3.015 | 3.506 | 3.249 | 2.519 | 0.348 | 0.076 | 0.983 | 0.777 | 0.084 | 0.052 | -0.136 | 1.121 | 0 |
Income Before Tax
| -20.725 | -22.076 | -21.447 | -22.455 | -23.935 | -23.945 | -27.206 | -27.531 | -25.98 | -14.797 | -7.935 | -8.464 | -12.342 | -14.822 | -11.402 | -14.028 | -9.754 | 0 |
Income Before Tax Ratio
| -2.008 | -1.946 | -2.03 | -2.67 | -4.169 | -5.762 | -8.2 | -4.775 | -4.486 | -3.055 | -2.254 | -3.097 | -4.191 | -3.813 | -3.133 | -4.688 | -4.22 | 0 |
Income Tax Expense
| -0.935 | -1.555 | -1.573 | -1.749 | -2.558 | 0.051 | 0.042 | 0.04 | -2.348 | 0 | 0 | 0 | -0.346 | 0.097 | 0.053 | 0.067 | 2.809 | 0 |
Net Income
| -19.79 | -20.521 | -19.874 | -20.706 | -21.377 | -23.996 | -27.248 | -27.571 | -25.98 | -14.797 | -7.935 | -8.464 | -12.342 | -14.822 | -11.402 | -14.028 | -9.754 | 0 |
Net Income Ratio
| -1.918 | -1.809 | -1.881 | -2.462 | -3.724 | -5.774 | -8.212 | -4.782 | -4.486 | -3.055 | -2.254 | -3.097 | -4.191 | -3.813 | -3.133 | -4.688 | -4.22 | 0 |
EPS
| -0.01 | -0.011 | -0.012 | -0.017 | -0.036 | -0.06 | -0.072 | -0.074 | -0.081 | -0.055 | -0.041 | -0.047 | -0.072 | -0.094 | -0.093 | -0.15 | -0.13 | 0 |
EPS Diluted
| -0.01 | -0.011 | -0.012 | -0.017 | -0.036 | -0.06 | -0.072 | -0.074 | -0.081 | -0.055 | -0.041 | -0.047 | -0.072 | -0.094 | -0.093 | -0.15 | -0.13 | 0 |
EBITDA
| -21.721 | -20.379 | -18.458 | -21.317 | -24.074 | -26.736 | -30.348 | -30.519 | -28.304 | -14.97 | -7.835 | -9.239 | -12.891 | -14.144 | -10.664 | -13.053 | -7.71 | 0 |
EBITDA Ratio
| -2.105 | -1.796 | -1.747 | -2.535 | -4.193 | -6.433 | -9.146 | -5.293 | -4.888 | -3.09 | -2.225 | -3.381 | -4.377 | -3.639 | -2.93 | -4.363 | -3.336 | 0 |